165 related articles for article (PubMed ID: 27221589)
1. Identification of Leishmania donovani Topoisomerase 1 inhibitors via intuitive scaffold hopping and bioisosteric modification of known Top 1 inhibitors.
Mamidala R; Majumdar P; Jha KK; Bathula C; Agarwal R; Chary MT; Majumder HK; Munshi P; Sen S
Sci Rep; 2016 May; 6():26603. PubMed ID: 27221589
[TBL] [Abstract][Full Text] [Related]
2. Discovery of Leishmania donovani topoisomerase IB selective inhibitors by targeting protein-protein interactions between the large and small subunits.
Lee H; Baek KH; Phan TN; Park IS; Lee S; Kim J; No JH
Biochem Biophys Res Commun; 2021 Sep; 569():193-198. PubMed ID: 34256188
[TBL] [Abstract][Full Text] [Related]
3. A Novel Spirooxindole Derivative Inhibits the Growth of Leishmania donovani Parasites both In Vitro and In Vivo by Targeting Type IB Topoisomerase.
Saha S; Acharya C; Pal U; Chowdhury SR; Sarkar K; Maiti NC; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2016 Oct; 60(10):6281-93. PubMed ID: 27503653
[TBL] [Abstract][Full Text] [Related]
4. Voacamine alters Leishmania ultrastructure and kills parasite by poisoning unusual bi-subunit topoisomerase IB.
Chowdhury SR; Kumar A; Godinho JLP; De Macedo Silva ST; Zuma AA; Saha S; Kumari N; Rodrigues JCF; Sundar S; Dujardin JC; Roy S; De Souza W; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2017 Aug; 138():19-30. PubMed ID: 28483460
[TBL] [Abstract][Full Text] [Related]
5. An insight into the active site of a type I DNA topoisomerase from the kinetoplastid protozoan Leishmania donovani.
Das A; Mandal C; Dasgupta A; Sengupta T; Majumder HK
Nucleic Acids Res; 2002 Feb; 30(3):794-802. PubMed ID: 11809893
[TBL] [Abstract][Full Text] [Related]
6. Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.
Diaz-González R; Pérez-Pertejo Y; Pommier Y; Balaña-Fouce R; Reguera RM
Biochem Pharmacol; 2008 Sep; 76(5):608-19. PubMed ID: 18655776
[TBL] [Abstract][Full Text] [Related]
7. Differential induction of Leishmania donovani bi-subunit topoisomerase I-DNA cleavage complex by selected flavones and camptothecin: activity of flavones against camptothecin-resistant topoisomerase I.
Das BB; Sen N; Roy A; Dasgupta SB; Ganguly A; Mohanta BC; Dinda B; Majumder HK
Nucleic Acids Res; 2006; 34(4):1121-32. PubMed ID: 16488884
[TBL] [Abstract][Full Text] [Related]
8. An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme.
Roy A; Das BB; Ganguly A; Bose Dasgupta S; Khalkho NV; Pal C; Dey S; Giri VS; Jaisankar P; Dey S; Majumder HK
Biochem J; 2008 Jan; 409(2):611-22. PubMed ID: 17922678
[TBL] [Abstract][Full Text] [Related]
9. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.
Davies DR; Mushtaq A; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2006 Apr; 357(4):1202-10. PubMed ID: 16487540
[TBL] [Abstract][Full Text] [Related]
10. A pentapeptide signature motif plays a pivotal role in Leishmania DNA topoisomerase IB activity and camptothecin sensitivity.
Prada CF; Alvarez-Velilla R; Diaz-González R; Prieto C; Pérez-Pertejo Y; Balaña-Fouce R; Reguera RM
Biochim Biophys Acta; 2012 Dec; 1820(12):2062-71. PubMed ID: 23000572
[TBL] [Abstract][Full Text] [Related]
11. Diospyrin, a bisnaphthoquinone: a novel inhibitor of type I DNA topoisomerase of Leishmania donovani.
Ray S; Hazra B; Mittra B; Das A; Majumder HK
Mol Pharmacol; 1998 Dec; 54(6):994-9. PubMed ID: 9855627
[TBL] [Abstract][Full Text] [Related]
12. Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies.
Sharma G; Chowdhury S; Sinha S; Majumder HK; Kumar SV
J Enzyme Inhib Med Chem; 2014 Apr; 29(2):185-9. PubMed ID: 23534930
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Leishmania donovani promastigote DNA topoisomerase I and human monocyte DNA topoisomerases I and II by antimonial drugs and classical antitopoisomerase agents.
Walker J; Saravia NG
J Parasitol; 2004 Oct; 90(5):1155-62. PubMed ID: 15562618
[TBL] [Abstract][Full Text] [Related]
14. Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani.
Díaz González R; Pérez Pertejo Y; Redondo CM; Pommier Y; Balaña-Fouce R; Reguera RM
Biochimie; 2007 Dec; 89(12):1517-27. PubMed ID: 17900785
[TBL] [Abstract][Full Text] [Related]
15. Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.
Das A; Dasgupta A; Sharma S; Ghosh M; Sengupta T; Bandopadhyay S; Majumder HK
Nucleic Acids Res; 2001 May; 29(9):1844-51. PubMed ID: 11328867
[TBL] [Abstract][Full Text] [Related]
16. Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy.
Chowdhury AR; Mandal S; Goswami A; Ghosh M; Mandal L; Chakraborty D; Ganguly A; Tripathi G; Mukhopadhyay S; Bandyopadhyay S; Majumder HK
Mol Med; 2003; 9(1-2):26-36. PubMed ID: 12765337
[TBL] [Abstract][Full Text] [Related]
17. 2-Alkynoic fatty acids inhibit topoisomerase IB from Leishmania donovani.
Carballeira NM; Cartagena M; Sanabria D; Tasdemir D; Prada CF; Reguera RM; Balaña-Fouce R
Bioorg Med Chem Lett; 2012 Oct; 22(19):6185-9. PubMed ID: 22932312
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of marine α-methoxylated fatty acid analogs that effectively inhibit the topoisomerase IB from Leishmania donovani with a mechanism different from that of camptothecin.
Carballeira NM; Montano N; Alvarez-Velilla R; Prada CF; Reguera RM; Balaña-Fouce R
Mar Drugs; 2013 Sep; 11(10):3661-75. PubMed ID: 24084785
[TBL] [Abstract][Full Text] [Related]
19. The lignan glycosides lyoniside and saracoside poison the unusual type IB topoisomerase of Leishmania donovani and kill the parasite both in vitro and in vivo.
Saha S; Mukherjee T; Chowdhury S; Mishra A; Chowdhury SR; Jaisankar P; Mukhopadhyay S; Majumder HK
Biochem Pharmacol; 2013 Dec; 86(12):1673-87. PubMed ID: 24134912
[TBL] [Abstract][Full Text] [Related]
20. Leishmania donovani: differential activities of classical topoisomerase inhibitors and antileishmanials against parasite and host cells at the level of DNA topoisomerase I and in cytotoxicity assays.
Jean-Moreno V; Rojas R; Goyeneche D; Coombs GH; Walker J
Exp Parasitol; 2006 Jan; 112(1):21-30. PubMed ID: 16293247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
